Skip to content

Clinical observation for thoracic sympathetic nerve block in the treatment of thoracic herpes zoster-related pain: a retrospective case-control study

Clinical observation for thoracic sympathetic nerve block in the treatment of thoracic herpes zoster-related pain: a retrospective case-control study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900022354
Enrollment
Unknown
Registered
2019-04-07
Start date
2019-04-14
Completion date
Unknown
Last updated
2019-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

zoster-related pain/herpetic neuralgia

Interventions

Group 1:Thoracic sympathetic nerve block+Bipolar High-Voltage, Long-Duration Pulsed Radiofrequency
Group 2:Bipolar High-Voltage, Long-Duration Pulsed Radiofrequency alone

Sponsors

The First Affiliated Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Understand and voluntarily endorse informed consent; 2. Male or female and 18 years of age or older; 3. One month after the rash onset; 4. Pain(rash site)is located between Thoracic3 to Thoracic10; 5. Patients who underwent Bipolar High-Voltage, Long-Duration Pulsed Radiofrequency in our department and the VAS?4 before the procedure; 6. Intraoperative imaging (Computed tomography) of patients can be found in hospital information system(HIS) 7. Patients who can be able to follow the drug dose and the follow-up plan; 8. Patients who can objectively describe the symptoms, can take the initiative to cooperate, without any mental illness.

Exclusion criteria

Exclusion criteria: Patients with malignant tumor or with a history of malignant tumor; patients who were diagnosed with psychiatric diseases; Patients with mild pain(Vas<4) before the procedure; No follow-up data after the procedure.

Design outcomes

Primary

MeasureTime frame
VisuaAnalogue Scale/Score(VAS);Daily sleep interference score(SIS);

Secondary

MeasureTime frame
analgesic (including antiepileptic agents) consumption;Complications of the procedure;

Countries

China

Contacts

Public ContactTao Song

The First Affiliated Hospital of China Medical University

songtaocmu@163.com+86 24-83282009

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026